{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:31:10Z","timestamp":1789749070741,"version":"4.0.1"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1213\/ane.0b013e3181a7c8e5","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T03:16:20Z","timestamp":1253070980000},"page":"1054-1064","source":"Crossref","is-referenced-by-count":78,"title":["The Myotonias and Susceptibility to Malignant Hyperthermia"],"prefix":"10.1213","volume":"109","author":[{"given":"Jerome","family":"Parness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Bandschapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210902","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1566524023362429","article-title":"Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins.","volume":"2","author":"Nelson","year":"2002","journal-title":"Curr Mol Med"},{"key":"R2-12-20210902","doi-asserted-by":"crossref","first-page":"37471","DOI":"10.1074\/jbc.M701379200","article-title":"Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations.","volume":"282","author":"Yang","year":"2007","journal-title":"J Biol Chem"},{"key":"R3-12-20210902","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease.","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"R4-12-20210902","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00415-002-0871-5","article-title":"Skeletal muscle channelopathies.","volume":"249","author":"Jurkat-Rott","year":"2002","journal-title":"J Neurol"},{"key":"R5-12-20210902","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nurt.2007.01.015","article-title":"Physiologic principles underlying ion channelopathies.","volume":"4","author":"Cannon","year":"2007","journal-title":"Neurotherapeutics"},{"key":"R6-12-20210902","doi-asserted-by":"crossref","first-page":"33477","DOI":"10.1074\/jbc.M602306200","article-title":"Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor.","volume":"281","author":"Zhao","year":"2006","journal-title":"J Biol Chem"},{"key":"R7-12-20210902","doi-asserted-by":"crossref","first-page":"15793","DOI":"10.1073\/pnas.0403485101","article-title":"Conformational activation of Ca2+ entry by depolarization of skeletal myotubes.","volume":"101","author":"Cherednichenko","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-12-20210902","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.1074\/jbc.M608942200","article-title":"Dynamic assembly of TRPC1\/STIM1\/Orai1 ternary complex is involved in store operated calcium influx: evidence for similarities in SOC and CRAC channel components.","volume":"282","author":"Ong","year":"2007","journal-title":"J Biol Chem"},{"key":"R9-12-20210902","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1073\/pnas.0611692104","article-title":"Orai proteins interact with TRPC channels and confer responsiveness to store depletion.","volume":"104","author":"Liao","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-12-20210902","doi-asserted-by":"crossref","first-page":"36994","DOI":"10.1074\/jbc.M506441200","article-title":"Ryanodine receptor type 1 (RyR1) mutations C4958S and C4961S reveal excitation-coupled calcium entry (ECCE) is independent of sarcoplasmic reticulum store depletion.","volume":"280","author":"Hurne","year":"2005","journal-title":"J Biol Chem"},{"key":"R11-12-20210902","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1113\/jphysiol.2008.160481","article-title":"Differential dependence of store-operated and excitation-coupled Ca2+ entry in skeletal muscle on STIM1 and Orai1.","volume":"586","author":"Lyfenko","year":"2008","journal-title":"J Physiol"},{"key":"R12-12-20210902","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1124\/mol.107.043299","article-title":"Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene.","volume":"73","author":"Cherednichenko","year":"2008","journal-title":"Mol Pharmacol"},{"key":"R13-12-20210902","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ncb1731","article-title":"STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle.","volume":"10","author":"Stiber","year":"2008","journal-title":"Nat Cell Biol"},{"key":"R14-12-20210902","article-title":"Stedman's Medical Dictionary. 23rd ed.","year":"1976"},{"key":"R15-12-20210902","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.nurt.2007.01.012","article-title":"The nondystrophic myotonias.","volume":"4","author":"Heatwole","year":"2007","journal-title":"Neurotherapeutics"},{"key":"R16-12-20210902","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/WCO.0b013e3282efc16c","article-title":"Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias.","volume":"20","author":"Ryan","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"R17-12-20210902","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/(SICI)1097-4598(199810)21:10<1334::AID-MUS16>3.0.CO;2-1","article-title":"Transient weakness and compound muscle action potential decrement in myotonia congenita.","volume":"21","author":"Deymeer","year":"1998","journal-title":"Muscle Nerve"},{"key":"R18-12-20210902","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1034\/j.1399-6576.2003.00116.x","article-title":"Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders.","volume":"47","author":"Farbu","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"key":"R19-12-20210902","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.0954-6820.1962.tb07216.x","article-title":"Myotonic human musculature: stimulation with depolarizing agents. II. A clinico-pharmacological study.","volume":"172","author":"Orndahl","year":"1962","journal-title":"Acta Med Scand"},{"key":"R20-12-20210902","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.38.5.810","article-title":"Malignant hyperthermia in myotonia congenita.","volume":"38","author":"Heiman-Patterson","year":"1988","journal-title":"Neurology"},{"key":"R21-12-20210902","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00000542-199505000-00002","article-title":"Masseter muscle rigidity associated with glycine1306-to- alanine mutation in the adult muscle sodium channel \u03b1-subunit gene.","volume":"82","author":"Vita","year":"1995","journal-title":"Anesthesiology"},{"key":"R22-12-20210902","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jama.1964.03070250011002","article-title":"Hyperthermia during anesthesia.","volume":"190","author":"Saidman","year":"1964","journal-title":"JAMA"},{"key":"R23-12-20210902","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2044.1989.tb11182.x","article-title":"Malignant hyperthermia and myotonia congenita (Thomsen's disease).","volume":"44","author":"Haberer","year":"1989","journal-title":"Anaesthesia"},{"key":"R24-12-20210902","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/bja\/55.1.57","article-title":"Failure to induce malignant hyperthermia in myotonic goats.","volume":"55","author":"Newberg","year":"1983","journal-title":"Br J Anaesth"},{"key":"R25-12-20210902","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/bja\/72.2.210","article-title":"Anaesthesia and myotonia.","volume":"72","author":"Russell","year":"1994","journal-title":"Br J Anaesth"},{"key":"R26-12-20210902","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/bja\/54.5.529","article-title":"Hazards of neostigmine in patients with neuromuscular disorders. Report of two cases.","volume":"54","author":"Buzello","year":"1982","journal-title":"Br J Anaesth"},{"key":"R27-12-20210902","first-page":"1293","article-title":"[Anesthetic managements of a patient with congenital myotonia (Becker type)].","volume":"53","author":"Hayashida","year":"2004","journal-title":"Masui"},{"key":"R28-12-20210902","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(02)00071-6","article-title":"Neurological disorders caused by inherited ion-channel mutations.","volume":"1","author":"Kullmann","year":"2002","journal-title":"Lancet Neurology"},{"key":"R29-12-20210902","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.22.8.810","article-title":"Hyperkalemic periodic paralysis and cardiac arrhythmia.","volume":"22","author":"Lisak","year":"1972","journal-title":"Neurology"},{"key":"R30-12-20210902","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01213011-200504000-00007","article-title":"Preferred mexiletine block of human sodium channels with IVS4 mutations and its pH-dependence.","volume":"15","author":"Mohammadi","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"R31-12-20210902","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1213\/01.ANE.0000093234.30458.D1","article-title":"Pyloromyotomy in a patient with paramyotonia congenita.","volume":"98","author":"Ay","year":"2004","journal-title":"Anesth Analg"},{"key":"R32-12-20210902","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.880100414","article-title":"Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH.","volume":"10","author":"Lehmann-Horn","year":"1987","journal-title":"Muscle Nerve"},{"key":"R33-12-20210902","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/WNL.52.7.1447","article-title":"Defective slow inactivation of sodium channels contributes to familial periodic paralysis.","volume":"52","author":"Hayward","year":"1999","journal-title":"Neurology"},{"key":"R34-12-20210902","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.neuro.29.051605.112815","article-title":"Pathomechanisms in channelopathies of skeletal muscle and brain.","volume":"29","author":"Cannon","year":"2006","journal-title":"Annu Rev Neurosci"},{"key":"R35-12-20210902","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2044.1992.tb02327.x","article-title":"Hyperkalaemic periodic paralysis and anaesthesia.","volume":"47","author":"Ashwood","year":"1992","journal-title":"Anaesthesia"},{"key":"R36-12-20210902","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00000542-200207000-00033","article-title":"Spinal anesthesia for a patient with familial hyperkalemic periodic paralysis.","volume":"97","author":"Weller","year":"2002","journal-title":"Anesthesiol"},{"key":"R37-12-20210902","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/bja\/34.5.340","article-title":"Generalized myotonia following suxamethonium. A case report.","volume":"34","author":"Paterson","year":"1962","journal-title":"Br J Anaesth"},{"key":"R38-12-20210902","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00000542-196801000-00043","article-title":"Muscle rigidity following administration of succinylcholine.","volume":"29","author":"Cody","year":"1968","journal-title":"Anesthesiology"},{"key":"R39-12-20210902","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000542-198908000-00023","article-title":"General anesthesia and hyperkalemic periodic paralysis.","volume":"71","author":"Aarons","year":"1989","journal-title":"Anesthesiology"},{"key":"R40-12-20210902","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nmd.2004.10.017","article-title":"Complications of anaesthesia in neuromuscular disorders.","volume":"15","author":"Klingler","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"R41-12-20210902","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/bja\/65.5.692","article-title":"Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?","volume":"65","author":"Lehmann-Horn","year":"1990","journal-title":"Br J Anaesth"},{"key":"R42-12-20210902","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1096-8628(19980226)76:1<21::AID-AJMG3>3.0.CO;2-S","article-title":"Linkage of malignant hyperthermia and hyperkalemic periodic paralysis to the adult skeletal muscle sodium channel (SCN4A) gene in a large pedigree.","volume":"76","author":"Moslehi","year":"1998","journal-title":"Am J Med Genet"},{"key":"R43-12-20210902","first-page":"1257","article-title":"Myology: basic and clinical. 3rd ed.","author":"Lehmann-Horn","year":"2004"},{"key":"R44-12-20210902","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2044.1992.tb04225.x","article-title":"Propofol in hyperkalaemic periodic paralysis.","volume":"47","author":"Cone","year":"1992","journal-title":"Anaesthesia"},{"key":"R45-12-20210902","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/00000539-200105000-00021","article-title":"Propofol blocks human skeletal muscle sodium channels in a voltage-dependent manner.","volume":"92","author":"Haeseler","year":"2001","journal-title":"Anesth Analg"},{"key":"R46-12-20210902","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0889-8537(02)00011-1","article-title":"Malignant hyperthermia and myotonic disorders.","volume":"20","author":"Rosenbaum","year":"2002","journal-title":"Anesthesiol Clin North America"},{"key":"R47-12-20210902","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D","article-title":"Genetics and pathogenesis of malignant hyperthermia.","volume":"23","author":"Jurkat-Rott","year":"2000","journal-title":"Muscle Nerve"},{"key":"R48-12-20210902","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrg1691","article-title":"Diseases of unstable repeat expansion: mechanisms and common principles.","volume":"6","author":"Gatchel","year":"2005","journal-title":"Nat Rev Genet"},{"key":"R49-12-20210902","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbadis.2006.05.013","article-title":"Myotonic dystrophy: emerging mechanisms for DM1 and DM2.","volume":"1772","author":"Cho","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"R50-12-20210902","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2004.09.012","article-title":"RNA pathogenesis of the myotonic dystrophies.","volume":"15","author":"Day","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"R51-12-20210902","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.spen.2006.06.002","article-title":"Myotonic dystrophies type 1 and 2: a summary on current aspects.","volume":"13","author":"Schara","year":"2006","journal-title":"Semin Pediatr Neurol"},{"key":"R52-12-20210902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20301","article-title":"Clinical and molecular aspects of the myotonic dystrophies: a review.","volume":"32","author":"Machuca-Tzili","year":"2005","journal-title":"Muscle Nerve"},{"key":"R53-12-20210902","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-540-34449-0_7","article-title":"Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.","volume":"44","author":"Kuyumcu-Martinez","year":"2006","journal-title":"Prog Mol Subcell Biol"},{"key":"R54-12-20210902","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMcibr064708","article-title":"A reversal of misfortune for myotonic dystrophy?","volume":"355","author":"Cooper","year":"2006","journal-title":"N Engl J Med"},{"key":"R55-12-20210902","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0960-8966(01)00238-3","article-title":"Intolerance to neuroleptics and susceptibility for malignant hyperthermia in a patient with proximal myotonic myopathy (PROMM) and schizophrenia.","volume":"12","author":"Schneider","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"R56-12-20210902","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/00000542-199505000-00001","article-title":"Anesthetic complications in muscle disorders.","volume":"82","author":"Iaizzo","year":"1995","journal-title":"Anesthesiology"},{"key":"R57-12-20210902","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1213\/00000539-199411000-00034","article-title":"Malignant hyperthermia in a patient with hypokalemic periodic paralysis.","volume":"79","author":"Lambert","year":"1994","journal-title":"Anesth Analg"},{"key":"R58-12-20210902","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00000542-198511000-00008","article-title":"Anesthetic management of a patient with hypokalemic familial periodic paralysis for coronary artery bypass surgery.","volume":"63","author":"Rollman","year":"1985","journal-title":"Anesthesiology"},{"key":"R59-12-20210902","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1469-7793.1999.00321.x","article-title":"Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes.","volume":"520","author":"Morrill","year":"1999","journal-title":"J Physiol"},{"key":"R60-12-20210902","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00000542-197510000-00018","article-title":"Anesthetic management of hypokalemic periodic paralysis.","volume":"43","author":"Siler","year":"1975","journal-title":"Anesthesiol"},{"key":"R61-12-20210902","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0310057X7700500114","article-title":"Case report: anaesthesia in familial hypokalaemic periodic paralysis.","volume":"5","author":"Bashford","year":"1977","journal-title":"Anaesth Intensive Care"},{"key":"R62-12-20210902","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/mus.10069","article-title":"Hypokalemic periodic paralysis associated with malignant hyperthermia.","volume":"25","author":"Rajabally","year":"2002","journal-title":"Muscle Nerve"},{"key":"R63-12-20210902","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mus.20068","article-title":"Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia.","volume":"30","author":"Marchant","year":"2004","journal-title":"Muscle Nerve"},{"key":"R64-12-20210902","first-page":"426","article-title":"Dyskalemic periodic paralysis and myotonia.","volume":"76","author":"Neuman","year":"1993","journal-title":"Anesth Analg"},{"key":"R65-12-20210902","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","article-title":"Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.","volume":"60","author":"Monnier","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R66-12-20210902","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ceca.2004.08.001","article-title":"Intracellular Ca(2+) dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved.","volume":"37","author":"Avila","year":"2005","journal-title":"Cell Calcium"},{"key":"R67-12-20210902","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","article-title":"Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm.","volume":"8","author":"Treves","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"R68-12-20210902","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility.","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"R69-12-20210902","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1213\/00000539-198808000-00014","article-title":"Atracurium and hypokalemic familial periodic paralysis.","volume":"67","author":"Rooney","year":"1988","journal-title":"Anesth Analg"},{"key":"R70-12-20210902","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0952-8180(91)90165-J","article-title":"Atracurium use in a patient with familial periodic paralysis.","volume":"3","author":"Laurito","year":"1991","journal-title":"J Clin Anesth"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ane.0b013e3181a7c8e5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:12:58Z","timestamp":1786111978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200910000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181a7c8e5","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}